Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer’s disease
Authors:
- Ellis PatrickEPEllis Patrick
- Sathyapriya RajagopalSRSathyapriya Rajagopal
- Hon-Kit Andus WongHWHon-Kit Andus Wong
- Cristin McCabeCMCristin McCabe
- Jishu XuJXJishu Xu
- Anna TangATAnna Tang
- Selina H. ImboywaSISelina H. Imboywa
- Julie A. SchneiderJSJulie A. Schneider
- Nathalie PochetNPNathalie Pochet
- Anna M. KrichevskyAKAnna M. Krichevsky
- Lori B. ChibnikLCLori B. Chibnik
- David A. BennettDBDavid A. Bennett
Open Access
- 1 July 2017
- journal article
- research article
- Published by Springer Nature in Molecular Neurodegeneration
- Vol. 12 (1) , 1-13
Abstract
Given multiple studies of brain microRNA (miRNA) in relation to Alzheimer’s disease (AD) with few consistent results and the heterogeneity of this disease, the objective of this study was to explore their mechanism by evaluating their relation to different elements of Alzheimer’s disease pathology, confounding factors and mRNA expression data from the same subjects in the same brain region. We report analyses of expression profiling of miRNA (n = 700 subjects) and lincRNA (n = 540 subjects) from the dorsolateral prefrontal cortex of individuals participating in two longitudinal cohort studies of aging. We confirm the association of two well-established miRNA (miR-132, miR-129) with pathologic AD in our dataset and then further characterize this association in terms of its component neuritic β-amyloid plaques and neurofibrillary tangle pathologies. Additionally, we identify one new miRNA (miR-99) and four lincRNA that are associated with these traits. Many other previously reported associations of microRNA with AD are associated with the confounders quantified in our longitudinal cohort. Finally, by performing analyses integrating both miRNA and RNA sequence data from the same individuals (525 samples), we characterize the impact of AD associated miRNA on human brain expression: we show that the effects of miR-132 and miR-129-5b converge on certain genes such as EP300 and find a role for miR200 and its target genes in AD using an integrated miRNA/mRNA analysis. Overall, miRNAs play a modest role in human AD, but we observe robust evidence that a small number of miRNAs are responsible for specific alterations in the cortical transcriptome that are associated with AD.Keywords
All Related Versions
Funding Information
- National Institute on Aging (R01 AG036042, R01 AG036836, R01 AG17917, RF1 AG15819, R01 AG032990, R01 AG18023, RC2 AG036547, P30 AG10161, U01 AG46152, P50 AG016574, U01 ES017155, K25 AG041906-01)
This publication has 41 references indexed in Scilit:
- Inferring data-specific micro-RNA function through the joint ranking of micro-RNA and pathways from matched micro-RNA and gene expression dataBioinformatics, 2015
- Mycobacterium tuberculosis Decreases Human Macrophage IFN-γ Responsiveness through miR-132 and miR-26aThe Journal of Immunology, 2014
- Tau promotes neurodegeneration through global chromatin relaxationNature Neuroscience, 2014
- lincRNAs: Genomics, Evolution, and MechanismsCell, 2013
- Mammalian microRNAs predominantly act to decrease target mRNA levelsNature, 2010
- Joint Genome-Wide Profiling of miRNA and mRNA Expression in Alzheimer's Disease Cortex Reveals Altered miRNA RegulationPLOS ONE, 2010
- Amyloid Deposition Is Associated with Impaired Default Network Function in Older Persons without DementiaNeuron, 2009
- Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of β-secretaseNature Medicine, 2008
- A microRNA-based gene dysregulation pathway in Huntington's diseaseNeurobiology of Disease, 2008
- Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.1997